Sign up
Quantellect · Analysts · Analyst Profile

Andrew Mok

Barclays · Equity Research Analyst

Analyst rating accuracy & track record

Andrew Mok does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
CICigna Corp
Buy$383.00Sep 2025−32.4%Miss
RDNTRadNet Inc
Buy$79.00Sep 2025−24.5%Hit
ADUSAddus HomeCare Corporation
Sell$109.00Aug 2025+24.9%Hit
AVAHAveanna Healthcare Holdings Inc
Buy$9.50Aug 2025+53.3%Hit
AGLagilon health Inc
Sell$1.50Aug 2025−267.8%Hit
UHSUniversal Health Services Inc
Buy$259.00Jul 2025−28.6%Miss
AGLagilon health Inc
Sell$3.00May 2025+35.0%Hit
EHCEncompass Health Corp
Buy$129.00Apr 2025−17.3%Miss
RDNTRadNet Inc
Buy$60.00Mar 2025+16.6%Hit
ALHCAlignment Healthcare LLC
Sell$9.00Feb 2025−18.8%Miss
EHCEncompass Health Corp
Buy$118.00Feb 2025−0.4%Hit
RDNTRadNet Inc
Buy$74.00Jan 2025+0.6%Hit
RDNTRadNet Inc
Buy$85.00Dec 2024−5.5%Hit
ALHCAlignment Healthcare LLC
Sell$8.00Oct 2024−38.1%Miss
EHCEncompass Health Corp
Buy$116.00Oct 2024+25.8%Hit
RDNTRadNet Inc
Buy$79.00Sep 2024+27.9%Hit
EHCEncompass Health Corp
Buy$109.00Aug 2024+47.0%Hit
Prev1Next
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.